Trial Profile
Measles-mumps-rubella and Measles-mumps-rubella-varicella Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2023
Price :
$35
*
At a glance
- Drugs Measles mumps and rubella virus vaccine-(Priorix) (Primary) ; MMR-varicella zoster virus vaccine (Primary)
- Indications Measles; Mumps; Rubella; Varicella zoster virus infections
- Focus Therapeutic Use
- 22 Mar 2016 New trial record